Global Cancer Genomic Testing Market Overview:
Global Cancer Genomic Testing Market Report 2026 provides a comprehensive analysis of the industry, covering key factors such as market trends, growth drivers, developments, size, and dynamics. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Cancer Genomic Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Cancer Genomic Testing Market
The Cancer Genomic Testing Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Cancer Genomic Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting the growth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Cancer Genomic Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Cancer Genomic Testing market has been segmented into:
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others
By Application, Cancer Genomic Testing market has been segmented into:
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East and Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Cancer Genomic Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Cancer Genomic Testing market.
Top Key Players Covered in Cancer Genomic Testing market are:
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Centogene AG
LabCorp
Color Genomics
Illumina Inc.
Gene By Gene Ltd.
23andMe Inc.
Bio-Rad Laboratories
Agilent Technologies
Thermo Fisher Scientific
Research Methodology:
Our report provides a detailed breakdown of the market, divided into segments like Type and Application, each with its own sub-categories. We also examine major competitors, looking at their market size, share, and recent activities such as mergers, acquisitions, and partnerships. This helps new and existing businesses in the Cancer Genomic Testing Market understand the competitive landscape and plan their strategies. We collect our data through two main methods:
1. Primary Research: Direct interviews with industry experts and insights from top research analysts.
2. Secondary Research: Information from company annual reports and public records.
We then analyze this data using proven methods like SWOT analysis, PORTER's Five Forces model, and PESTLE analysis to ensure accuracy and reliability.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Cancer Genomic Testing Market by Type
4.1 Cancer Genomic Testing Market Snapshot and Growth Engine
4.2 Cancer Genomic Testing Market Overview
4.3 Breast Cancer Genomic Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Breast Cancer Genomic Testing: Geographic Segmentation Analysis
4.4 Lung Cancer Genomic Testing
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Lung Cancer Genomic Testing: Geographic Segmentation Analysis
4.5 Blood Cancer Genomic Testing
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Blood Cancer Genomic Testing: Geographic Segmentation Analysis
4.6 Liver Cancer Genomic Testing
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Liver Cancer Genomic Testing: Geographic Segmentation Analysis
4.7 Stomach Cancer Genomic Testing
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Stomach Cancer Genomic Testing: Geographic Segmentation Analysis
4.8 Others
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Others: Geographic Segmentation Analysis
Chapter 5: Cancer Genomic Testing Market by Application
5.1 Cancer Genomic Testing Market Snapshot and Growth Engine
5.2 Cancer Genomic Testing Market Overview
5.3 Hospitals
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Hospitals: Geographic Segmentation Analysis
5.4 Clinics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Clinics: Geographic Segmentation Analysis
5.5 Diagnostic Laboratories
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Diagnostic Laboratories: Geographic Segmentation Analysis
5.6 Academic and Research Institutes
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Academic and Research Institutes: Geographic Segmentation Analysis
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Cancer Genomic Testing Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MYRIAD GENETICS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 POSITIVE BIOSCIENCE
6.4 QUEST DIAGNOSTICS
6.5 CENTOGENE AG
6.6 LABCORP
6.7 COLOR GENOMICS
6.8 ILLUMINA INC.
6.9 GENE BY GENE LTD.
6.10 23ANDME INC.
6.11 BIO-RAD LABORATORIES
6.12 AGILENT TECHNOLOGIES
6.13 THERMO FISHER SCIENTIFIC
Chapter 7: Global Cancer Genomic Testing Market By Region
7.1 Overview
7.2. North America Cancer Genomic Testing Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Breast Cancer Genomic Testing
7.2.4.2 Lung Cancer Genomic Testing
7.2.4.3 Blood Cancer Genomic Testing
7.2.4.4 Liver Cancer Genomic Testing
7.2.4.5 Stomach Cancer Genomic Testing
7.2.4.6 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Hospitals
7.2.5.2 Clinics
7.2.5.3 Diagnostic Laboratories
7.2.5.4 Academic and Research Institutes
7.2.5.5 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Cancer Genomic Testing Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Breast Cancer Genomic Testing
7.3.4.2 Lung Cancer Genomic Testing
7.3.4.3 Blood Cancer Genomic Testing
7.3.4.4 Liver Cancer Genomic Testing
7.3.4.5 Stomach Cancer Genomic Testing
7.3.4.6 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Hospitals
7.3.5.2 Clinics
7.3.5.3 Diagnostic Laboratories
7.3.5.4 Academic and Research Institutes
7.3.5.5 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Cancer Genomic Testing Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Breast Cancer Genomic Testing
7.4.4.2 Lung Cancer Genomic Testing
7.4.4.3 Blood Cancer Genomic Testing
7.4.4.4 Liver Cancer Genomic Testing
7.4.4.5 Stomach Cancer Genomic Testing
7.4.4.6 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Hospitals
7.4.5.2 Clinics
7.4.5.3 Diagnostic Laboratories
7.4.5.4 Academic and Research Institutes
7.4.5.5 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Cancer Genomic Testing Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Breast Cancer Genomic Testing
7.5.4.2 Lung Cancer Genomic Testing
7.5.4.3 Blood Cancer Genomic Testing
7.5.4.4 Liver Cancer Genomic Testing
7.5.4.5 Stomach Cancer Genomic Testing
7.5.4.6 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Hospitals
7.5.5.2 Clinics
7.5.5.3 Diagnostic Laboratories
7.5.5.4 Academic and Research Institutes
7.5.5.5 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East and Africa Cancer Genomic Testing Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Breast Cancer Genomic Testing
7.6.4.2 Lung Cancer Genomic Testing
7.6.4.3 Blood Cancer Genomic Testing
7.6.4.4 Liver Cancer Genomic Testing
7.6.4.5 Stomach Cancer Genomic Testing
7.6.4.6 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Hospitals
7.6.5.2 Clinics
7.6.5.3 Diagnostic Laboratories
7.6.5.4 Academic and Research Institutes
7.6.5.5 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Cancer Genomic Testing Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Breast Cancer Genomic Testing
7.7.4.2 Lung Cancer Genomic Testing
7.7.4.3 Blood Cancer Genomic Testing
7.7.4.4 Liver Cancer Genomic Testing
7.7.4.5 Stomach Cancer Genomic Testing
7.7.4.6 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Hospitals
7.7.5.2 Clinics
7.7.5.3 Diagnostic Laboratories
7.7.5.4 Academic and Research Institutes
7.7.5.5 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Cancer Genomic Testing Scope:
|
Report Data
|
Cancer Genomic Testing Market
|
|
Cancer Genomic Testing Market Size in 2025
|
USD XX million
|
|
Cancer Genomic Testing CAGR 2025 - 2032
|
XX%
|
|
Cancer Genomic Testing Base Year
|
2024
|
|
Cancer Genomic Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Myriad Genetics, Positive Bioscience, Quest Diagnostics, Centogene AG, LabCorp, Color Genomics, Illumina Inc., Gene By Gene Ltd., 23andMe Inc., Bio-Rad Laboratories, Agilent Technologies, Thermo Fisher Scientific.
|
|
Key Segments
|
By Type
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others
By Applications
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
|
